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Abstract
Our study tested the hypothesis that immunoglobulins differ in their ability to activate the
nuclear factor-κB pathway mediated cellular responses. These responses are modulated
by several properties of the immune complex, including the ratio of antibody isotypes bind-
ing to antigen. Immunoassays allow the measurement of antigen specific antibodies
belonging to distinct immunoglobulin classes and subclasses but not the net biological
effect of the combination of these antibodies. We set out to develop a biosensor that is suit-
able for the detection and characterization of antigen specific serum antibodies. We geneti-
cally modified the monocytoid U937 cell line carrying Fc receptors with a plasmid encoding
NF-κB promoter-driven GFP. This clone, U937-NF-κB, was characterized with respect to
FcR expression and response to solid-phase immunoglobulins. Human IgG3, IgG4 and
IgG1 induced GFP production in a time- and dose-dependent manner, in this order of effi-
cacy, while IgG2 triggered no activation at the concentrations tested. IgA elicited no
response alone but showed significant synergism with IgG3 and IgG4. We confirmed the
importance of activation via FcγRI by direct stimulation with monoclonal antibody and by
competition assays. We used citrullinated peptides and serum from rheumatoid arthritis
patients to generate immune complexes and to study the activation of U937-NF-κB, observ-
ing again a synergistic effect between IgG and IgA. Our results show that immunoglobulins
have distinct pro-inflammatory potential, and that U937-NF-κB is suitable for the estimation
of biological effects of immune-complexes, offering insight into monocyte activation and
pathogenesis of antibody mediated diseases.
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Introduction
Understanding immunoglobulin-mediated activation of myeloid cells is of great interest in the
study of autoimmune conditions. Myeloid cells expressing receptors for the Fc part of immu-
noglobulins bridge adaptive and innate immunity. Different cell types in this group may medi-
ate various effector functions through their Fc receptors (FcRs) after engagement with
multimeric immunoglobulins (Ig). These include phagocytosis, expression of cytokines [1] and
chemokines, as well as release of inflammatory mediators and reactive oxygen species [2]. In
our work we focused on the nuclear factor-κB (NF-κB) transcription factor [3] mediated acti-
vation in monocytic cell line U937 [4] in response to immunoglobulin isotypes.
The system we applied here is based on the work of the Rosales group. They were the first to
show, that among many other ligands, multimeric IgG (or mimicking it through cross-linking
Fc receptors) initiates the signaling of the NF-κB pathway through FcRs in monocytes [5], and
identified the steps leading to activation of genes under the control of NF-κB responsive ele-
ments [6].
The example of IgG-FcγR interaction illustrates well the complexity of various aspects that
may affect the antibody triggered cell activation. Glycosylation [7], allotype [8],affinity and iso-
type distribution of antigen specific immunoglobulins along with Fc receptor polymorphism
[9], Fc receptor copy number variations [10], and surrogate receptors [11] were all shown to be
significantly modifying IgG-FcγR interaction, thus contributing to the fine-tuning of the
immune response. This recent flare in our understanding regarding both immunoglobulin
structure variety and its interaction with the immune system through Fc receptors, calls for the
development of techniques capable of detecting immunoglobulins in a more biological sense.
Our hypothesis in this study was that measurement of activation levels induced by various
immunoglobulins could help us (i) to reveal differences in their proinflammatory potential,
and (ii) to detect the presence of antigen specific antibody response from autoimmune biologi-
cal samples. For our investigations we used premonocytic cell line U937, a widely used model
for monocytes. The receptor repertoire of these cells include receptors for IgG, such as the high
affinity FcγRI and the low affinity FcγRIIAR131 [12], as well as FcαRI [13], the low affinity
receptor for IgA. The IgG subclasses: IgG1, IgG2, IgG3 and IgG4, were shown to differ in bind-
ing to FcγRs. FcγRI can bind IgG1, IgG3 and IgG4 with high affinity, but not IgG2, while
FcγRIIR131 has lower affinity to IgG1, IgG3 and IgG4, and shows weak binding to IgG2 [14],
yet their contribution to NF-κB activation remained unexplored. Microbial products are
known to trigger NF-κB translocation in innate immune cells through recognition by pattern
recognition receptors [15]. Bacterial lipopolysaccharide (LPS), a potent activator of NF-κB
translocation in monocytes, as well as in U937 cells [16,17], signals through CD14 and toll like
receptor 4 (TLR4) [18], which are both expressed on U937 cells [19] [20].
Rheumatoid Arthritis (RA) is a systemic autoimmune disease, where sustained inflamma-
tion can result in irreversible injury of joints and erosion of bone [21]. Among other character-
istics presence of autoantibodies and elevated levels of various inflammatory cytokines are
important factors of the disease. Anti-citrullinated peptide antibodies (ACPA) are found in the
majority of RA patients and used as a biomarker of the disease [22], and their pathogenic role
is also suggested [23]. Monocytes are suspected to play a central role in RA, by connecting
autoantibodies to cytokine production, as well as by their potential to differentiate into osteo-
clasts, the effector cells of bone resorption. These cells are therefore suggested targets of RA
treatment [24].
We stably transfected the U937 cell line with an NF-κB Responsive Element-driven GFP,
and measured the production of green fluorescent protein (GFP) with different fluorescent
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methods upon activation by various stimuli with the focus on immunoglobulins to determine
their inflammatory potential.
Materials and Methods
Serum samples and ethics statement
Serum samples from RA patients (n = 30) and healthy controls (n = 10) were obtained by veno-
puncture at University of Pécs and at University of Pisa (PISA) and were stored at -70°C until
use. RA patients fulfilled the international criteria [25].
The relevant ethics committees of Hungary (Egészségügyi Tudományos Tanács, Tudomá-
nyos és Kutatásetikai Bizottság) and Italy (Comitato Etico Area Vasta Nordovest, Azienda
Ospedaliera Universitaria Pisana, Pisa) gave their approval for conducting study with the fol-
lowing contract numbers, respectively: 24973-1/2012/EKU (658/PI/2012.), 45066/2012. Writ-
ten informed consent was obtained from all participants.
Cell Culture
Human premonocytic cell line, U937 (ATCC1 CRL-1593.2™) [4] and its stably transfected
derivative, U937-NF-κB were cultured in RPMI-1640 medium supplemented with 10% fetal
bovine serum (FBS), 2 mM glutamine, 100 IU/ml penicillin, 100 μg/ml streptomycin and 1mM
Na-pyruvate. Cells were maintained in a humidified atmosphere (5% CO2) at 37°C. All materi-
als were obtained from Sigma-Aldrich (St. Louis, MO, USA).
Antibodies and reagents
Labeled antibodies: PE-conjugated anti-human FcγRI (clone 10.1, IgG1 isotype), anti-human
FcγRII (clone FUN-2, IgG2b isotype), anti-humanFcγRIII (clone 3G8, IgG1 isotype), anti-
human FcαRI (clone A59, IgG1 isotype), mouse IgG1 (clone MOPC-21) and mouse IgG2b
(clone MPC-11) were purchased from Biolegend (San Diego, CA, USA).
Non-conjugated antibodies: anti-human FcγRI (clone 10.1, IgG1 isotype) anti-human
FcγRII (clone AT10, IgG1 isotype) and anti-human FcγRIII (clone 3G8, IgG1 isotype), were
obtained from Abcam (Cambridge, UK). Human IgG, human IgG1, human IgG2, human
IgG3, human IgG4, human IgM, human IgA were purchased from Sigma-Aldrich, goat anti-
human IgG fragment (GAH-IgG F(ab’)2) was obtained from Jackson Immunoresearch (West
Grove, PA, USA).
LPS and bovine serum albumin (BSA) were purchased from Sigma-Aldrich. FcR blocking
reagent obtained from Miltenyi Biotec (Bergisch Gladbach, Germany). Viral citrullinated pep-
tide 2 (VCP2) was prepared by solid-phase peptide synthesis and characterized by MALDI-MS
at the University of Florence. Hoechst 33342 stain was from Life Technologies/Thermo Fisher
(Waltham, MA, USA).
Stable transfection of U937 cells with a pNF-κB-GFP reporter plasmid
To generate U937-NF-κB, U937 cells were transfected as described by Ward et al. [26]. Briefly
10 μg pNFkB-PtGFP.2 (Xactagen, Shoreline, WA, USA) plasmid was added to 2107 cell in
400 μl RPMI-1640 without supplements in electroporation cuvette, the cells were electropo-
rated at 960 μF and 0.17 kV. After selection with 1 mg/ml G418, cells were plated and resistant
clones were isolated on the basis GFP production triggered by LPS.
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Characterization of receptor expression profiles in U937and U937-NF-
κB cells by FACS analysis
1105 U937 and U937-NF-κB cells were stained with PE-conjugated anti-FcγRI, anti-FcγRII,
anti-FcγRIII, anti-FcαRI, as well as IgG1 and IgG2b isotype controls for 20 min on ice, followed
by one wash with phosphate-buffered saline (PBS) +1% FBS azide buffer and the cells were
analyzed by flow cytometry. In all flow cytometry analysis 3104 cultured cells were measured
by FACSCalibur (Becton-Dickinson, Franklikes, NJ, USA) and analyzed by FCS Express V3
(De Novo software, Los Angeles, CA, USA).
In vitro activation of U937-NF-κB cells by immunoglobulin and LPS
Each cell activation assays were carried out in 96-well, flat bottom cell culture microplates
(Greiner, 655180). In this experiment the surface was coated with 50 μl 10 μg/ml human IgG
diluted in sterile PBS and incubated for 1 h at 37°C. Following this, the plate was washed twice
with sterile PBS, and once with RPMI 1640 +10% FBS (medium). 1105 U937-NF-κB cells
were added to the wells in 300 μl medium. For positive control 10 μg/ml soluble LPS, for nega-
tive control 10 μg/ml soluble human IgG was added directly to the cells seeded in uncoated
wells. To block cell activation on human IgG-coated surfaces, prior to incubation with cells, the
wells were treated with 10 μg/ml GAH-IgG F(ab’)2 in sterile PBS for 1 h, at room temperature
(RT) to mask surface bound IgG, then washed twice with 100 μl PBS and once with 100 μl
RPMI+10% FBS. The U937-NF-κB cells were seeded at a density of 1105 cell/well in 300 μl
medium and were incubated for 24 h, at 37°C.
The activation was also measured on anti-FcγR-coated surfaces. 50 μl anti-human FcγRI,
FcγRII or FcγRIII antibodies were immobilized in serial dilution from 20 μg/ml to 1.25 μg/ml
in sterile PBS and incubated for 1 h at 37°C. After washing steps mentioned above, 1105
U937-NF-κB cells were added to the wells and analyzed by flow cytometry.
Time- and dose-dependent activation of U937-NF-κB cells
The surface of 96-well, flat bottom cell culture microplates were coated with BSA, human
IgG1, IgG2, IgG3, IgG4, IgA or IgM in two-fold serial dilutions from 20 μg/ml to 1.25 μg/ml in
sterile PBS and incubated for 1 h, at 37°C. The plates were washed twice with sterile PBS, and
once with RPMI 1640+10% FBS (medium). 1105 U937-NF-κB cells stained with 0.1 μM
Hoechst 33342 were seeded in 300 μl medium. For positive control soluble LPS was added to
the cells in serial dilution from 20 μg/ml to 1.25 μg/ml in medium. After a one hour long adhe-
sion period, the cells were assessed by a high content screening system (HCS) in every 2 hours
for an additional 12 hours (for further technical details see below).
Blocking of U937 FcRs with human IgG subclasses
10 μg/ml human IgG4 diluted in sterile PBS was coated for 1 h at 37°C. The U937-NF-κB cells
pellet were pre-treated directly with 10 μg/ml, 20 μg/ml, and 30 μg/ml soluble human IgG1,
IgG3 or IgG4 for 20 min at 37°C, after incubation the cells were washed with medium The
plate was washed twice with 100 μl PBS and once with 100 μl RPMI+10% FBS. The U937-NF-
κB cells were seeded at a density of 1105 cell/well in 300 μl medium and incubated for 24 h, at
37°C and analyzed by flow cytometry.
Cell activation by combination of human IgG subclasses and human IgA
Human IgG subclasses at 5 μg/ml concentration, diluted in sterile PBS were coated combined
with 5 μg/ml or 10 μg/ml human IgA diluted in the same buffer. For controls the
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immunoglobulin subclasses were coated alone in a concentration of 5 μg/ml in sterile PBS. The
U937-NF-κB cells were seeded at a density of 1105/well in 300 μl medium, incubated for 24 h,
at 37°C and analyzed by flow cytometry.
In vitro activation of U937-NF-κB cells by immune complexes
96-well, flat bottom plates were coated with 50–50 μl 20 μg/ml VCP2 peptide in sterile PBS and
incubated for overnight at 4°C. After incubation, the wells were washed three times with 100 μl
PBS, and blocked with 50 μl 3% BSA for 45 min at RT on orbital shaker. RA patients’ sera were
diluted in 1:10 with 25 mM ethylenediaminetetraacetic acid (EDTA) contained 1% BSA and
50 μl diluted serum samples were added to each wells, and incubated for 3 h at RT on orbital
shaker. Subsequently, the wells were washed twice with 100 μl sterile PBS and once with RPMI
1640+10% FBS. 1105 U937-NF-κB cells stained with 0.1 μMHoechst 33342 were added to the
wells, and incubated for 10 h at 37°C, then assessed by HCS equipment.
HCSmeasurement and data analysis
The dose- and time-dependent assays, as well as immune complex-induced cell activation mea-
surements were carried out with an ImageXpress1Micro XL (Molecular Devices, Sunnyvale,
CA USA) high content screening system using a Nikon CFI Super Plan Fluor ELWD ADM 20x
objective. The fluorescence signals for Hoechst (447/60 nm) and GFP (536/40 nm) were
acquired at 377/50 and 482/35 nm excitations, respectively. The cells were kept at 37°C in a
humidified atmosphere containing 5% CO2 throughout the measurements. Ten images per
field with 2x binning were collected in both blue and green channels with 50 ms and 200 ms
exposure times, respectively.
For analysis, MetaXpress1High Content Image Acquisition & Analysis Software Version
5.3 was used. The cells were counted in a size range of 6–35 μm. The geometric mean values of
GFP signal in individual cells were analyzed by R version 3.2.0. The graphical evaluation of
geometric mean values were carried out with GraphPad Prism 5.
Microarray measurement and analysis
VCP2 diluted in MilliQ water to 4 mg/ml were printed onto 16-pad nitrocellulose-covered
FAST slides (Main Manufacturing, Grand Blanc, MI, USA) by sciFlexarrayer S11 (Scienion
AG, sciArraying service, Berlin, Germany) in triplicates, then stored at 4°C in sealed bags.
Dried arrays were rinsed in PBS for 15 minutes before use, then 5-fold diluted serum, in 25mM
EDTA, 0.05% Tween 20 and 5% BSA complemented PBS buffer was incubated at 37°C for 1
hour. Serum treated slides were washed with PBS containing 0.05% Tween 20 (PBS-T), then
incubated with 1:2500 diluted DyLight 649-conjugated F(ab’)2 fragment goat anti-human IgG
(Jackson ImmunoResearch) or with 1:1000 diluted Cy5-conjugated F(ab’)2 fragment goat anti-
human IgA (Jackson ImmunoResearch). Labeling with fluorescent antibodies was carried out
at room temperature for 30 minutes in PBS containing 5% BSA and 0.05% Tween 20. After
washing in PBS-T, arrays were dried and scanned by FLAIR Fluorescent Array Imaging Reader
(Sensovation). Data were analyzed by Array-Reader software by Sensovation, Radolfzell, Ger-
many. Signal intensities were calculated by subtracting local background from medians of the
three parallel signal intensities. Negative signals values were clamped to arbitrary value 1. Nor-
malization procedure was carried out in two steps. First, slide to slide normalization was
applied separately in the two printed batches. Slide specific normalization factors were calcu-
lated based on the signals in the subarray that was treated only with buffer but not serum sam-
ple. Human IgG and IgA features on arrays were used for normalization of IgG and IgA
signals, respectively. This adjustment compensated for both overall biological variations in the
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samples and technical differences in the detection. A second normalization step was applied to
compensate the possible differences in the two printing batches. Values in a given batch were
divided by geometric means of values derived from the given antigen in control samples.
Statistical Analysis
Mean ± SEM values were depicted on the graphs and unpaired Student's t test was used to eval-
uate significant differences as compare to the controls. For immune complex mediated cell acti-
vation analysis, groups were compared by the Kruskal-Wallis test followed by Dunn's multiple
comparison test. The calculations were carried out with GraphPad version 5 using a signifi-
cance level of 95% (p<0.05).
Results
Cell surface receptor profile of U937 remained unchanged following
transfection
Monocytoid cell line, U937 was stably transfected with a plasmid encoding NF-κB Responsive
Element-driven GFP. After selection, cells were cloned and U937-NF-κB was generated. U937
cell expresses the high affinity FcγRI, the low affinity FcγRII for IgG receptors and FcαRI IgA
receptor. U937 (Fig 1A) and U937-NF-κB (Fig 1B) cells were labeled with anti-FcγRI, anti-
FcγRII, anti-FcγRIII and anti-FcαRI antibodies. The Fc receptor expression patterns remained
unchanged in U937 cells after transfection (Fig 1).
U937-NF-κB cells express GFP upon activation by LPS or IgG
First, we tested U937-NF-κB responsivity with LPS, a widely used inducer of the NF-κB activa-
tion. U937-NF-κB cells expressed GFP in a time dependent fashion, reaching maximal fluores-
cence in about 12 hours, while untreated cells retain their baseline expression (Fig 2A). Next
we investigated whether hIgG had the same activating effect on U937-NF-κB. Cells were incu-
bated either on IgG coated surface or with soluble IgG. Immobilized IgG was indeed capable
promoting GFP production in these cells, while IgG in solution triggered no activation. To ver-
ify that activation occurred through the Fc part of the antibodies, we tested cell activation
Fig 1. Expression of Ig receptors on the U937-NF-κB reporter cell line. U937 cells express FcγRI, FcγRII, FcαRI of Fc receptors (A). Transfection
with NF-κB-GFP did not alter the Fc receptor expression patterns in the U937 cell line (B). U937 and U937-NF-κB cells were labeled with PE-conjugated
anti-FcγRI, FcγRII, FcγRIII and FcαRI, antibodies. The histograms show the unlabeled cells (filled histogram), the corresponding isotype control labeled
cells (dashed line) and the specific antibody stained cells (solid line).
doi:10.1371/journal.pone.0156328.g001
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following blocking the coated hIgG with anti-human IgG F(ab’)2 and found that this treatment
completely abolished cell activation on the human IgG coated surface (Fig 2B). These data
demonstrate that the NF-κB signaling pathway and the GFP expression were inducible by
cross-linking the Fcγ receptors with immobilized immunoglobulin.
Immobilized immunoglobulin triggers dose-dependent GFP production
of U937-NF-κB cells
To see how human Ig isotypes activate GFP production, U937-NF-κB cells were incubated on
increasing amounts of hIgG subclasses, hIgA and hIgM for 13 hours, their fluorescence intensi-
ties were recorded every two hours (Fig 3). Incubation of U937-NF-κB cells on surface coated
with human IgG3 (Fig 3C) or IgG4 (Fig 3D) effectively activated GFP production in U937-NF-
κB cells, while IgG1 (Fig 3A) had a very feeble effect. IgG2 (Fig 3B), IgA (Fig 3E) and IgM (Fig
3F) were ineffective. LPS-induced cell activation served as positive control (Fig 3G). The GFP
expression on immunoglobulin coated surfaces reached its maximum after 10 hours.
The activation of U937-NF-κB cells mainly occurred through the high
affinity FcγRI
To distinguish how distinct FcγRs expressed on U937-NF-κB cells contribute to the activation
of NF-κB pathway, we measured cell activation on immobilized monoclonal antibodies against
FcγRI, FcγRII, or FcγRIII (Fig 4A). The activation by anti-FcγRI coat was proved to be the
most effective stimulus as compared to anti-FcγRIII coat, which was used as a negative control.
The anti-FcγRII antibody coated surface also enhanced GFP production, yet to a much lower
extent than in the case of anti-FcγRI antibody, suggesting FcγRI to be more relevant in the
FcγR-mediated NF-κB activation in the U937-NF-κB cells To further expand this observation
we analyzed U937-NF-κB activation on immobilized IgG4 following incubation of the cells
with soluble IgG1, IgG3 and IgG4 (Fig 4B). As FcγRI can bind monomeric IgG, we expected
that its saturation would result in reduced GFP production on IgG4 coat because of competi-
tion between soluble and immobilized IgG. IgG4 has high affinity to FcγRI but not to FcγRII,
thus, FcγRI is expected to trigger activation by IgG4. The affinity of FcγRI to IgG4 is slightly
lower than to IgG1 and to IgG3 [14]. Soluble sIgG1 and sIgG3 reduced the cell activation on
human IgG4 coated surface at smaller dose as compared to the effect of sIgG4. By increasing
Fig 2. Detection of NF-κB activation by U937-NF-κB cells.Cells were treated with 10 μg/ml LPS (A), and
the activation was detected for 24 h. Cells subjected to the medium only served as a negative control. The
activation reached the maximum at 12 h. Cells were also activated on 10 μg/ml human immunoglobulin G
(hIgG) coated surface (B). For negative controls, cells subjected to the medium only or to 10 μg/ml soluble
human immunoglobulin (shIgG) on uncoated surface were used. The activation was tested on human
immunoglobulin coat in the presence of 10 μg/ml goat-anti human immunoglobulin (F(ab’)2).
doi:10.1371/journal.pone.0156328.g002
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Fig 3. Time- and dose-dependent activation of U937-NF-κB cells. The activation of U937-NF-κB cells was screened on plates coated with
BSA, human IgG1, IgG2, IgG3, IgG4, IgA, or IgM in two-fold serial dilution from 20 μg/ml to 1.25 μg/ml concentration. Following a one hour
adhesion period, the cells were imaged for 12 hours by HCS (A-F). The results were normalized to the fluorescence intensities of cells measured
on BSA coat. Soluble form of LPS served as positive control (G).
doi:10.1371/journal.pone.0156328.g003
Fig 4. Activation of U937-NF-κB cells occursmainly through FcγRI. The U937-NF-κB cells were activated on anti-FcγR-coated surfaces (A). FcγRI
cross-linking induces strong, while FcγRII results in weaker activation. The cell activation was measured on IgG4-coated surfaces (B, C, D) in the
presence of soluble IgG1(B), IgG3 (C) and IgG4 (D) in three doses (10, 20, 30 μg/ml). The untreated cells on IgG4 coat served as control (black bars).
Results are mean% ± SEM% (n = 9) *p<0.05 versus control (untreated cells).
doi:10.1371/journal.pone.0156328.g004
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the dose of sIgG1 the activation was inhibited by 13% to 46%, in the case of sIgG3 the inhibi-
tion was 29% to 77%, whereas sIgG4 blocked the cell activation significantly only at the highest
dose by 40%. These results suggest that the after partial saturation of the FcγRI, the receptor
bound IgG molecules will compete with those in immune-complexes for FcγRI, thus only the
IgG subclasses binding with higher affinity to FcγRI could trigger activation through these
receptors.
IgA shows synergism when combined with IgG
As IgA alone did not activate the cells, we intended to determine, whether it had an effect in
combination with activating IgG. We prepared combinations of IgG subclasses and IgA in vari-
ous ratios. The activation significantly increased by combining IgA with IgG3, while with IgG4
the trend was obvious, yet non-significant (Fig 5). In the case of IgG1 and IgG2 coats, addition
of IgA did not changed the activation of U937-NF-κB cells. Biological detection of autoanti-
bodies using the reporter cell incorporates therefore the integrated measurement of IgA and
IgG antibody isotypes that potentially trigger NF-κB activation and thus contribute to the
inflammation in the body.
NF-κB translocation mediated de novo protein synthesis triggered by by
immune complexes is detectable by U937-NF-κB cells
To see how U937-NF-κB cells are capable of detecting activating immune complexes, we gener-
ated immune complexes by incubation of sera from rheumatoid arthritis patients with RA spe-
cific citrullinated peptide: VCP2. We selected the samples on the basis of their VCP2-specific IgG
and IgA reactivity (Fig 6A), classifying them into four groups: double positive IgG+IgA+, single
positive IgG-IgA+ or IgG+IgA-, and double negative IgG-IgA-. IgG+IgA+ samples were the
most effective in activating U937-NF-κB cells, while one sample from the IgG+IgA-, and none
from the IgG-IgA+ and IgG-IgA- were able to trigger GFP production in the U937-NF-κB cells.
The generated reporter cells are therefore suitable for the detection of proinflammatory immune
complexes.
Fig 5. Activation of U937-NF-κB cells on IgG-coated surfaces in combination with IgA coat. U937-NF-
κB cells were activated on surfaces coated with 5 μg/ml IgG1 (A), IgG2 (B), IgG3 (C), or IgG4 (D) and with 5
or 10 μg/ml IgA. The mean fluorescence intensities of the cells exposed to IgGs were normalized to the
fluorescence intensities of untreated cells (medium only). For the analysis of combined IgG and IgA effects
these normalized values were further divided by the respective IgA treatment values. Results are mean
% ± SEM (n = 6) *p<0.05 versus control (without IgA).
doi:10.1371/journal.pone.0156328.g005
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Discussion
The monocytic U937 cells, used here to model monocyte/macrophage responses, and the gen-
erated U937-NF-κB cells express two IgG receptors, FcγRI and FcγRII, and the IgA receptor
FcαRI. It also known that they express the R131 variant of FcγRIIA [27], and a recent report
shows that FcγRIIB is not expressed on this cell line [12]. Signaling via these receptors is
expected to be responsible for our observations as have been shown previously for monocytes
by cross-linking FcγRI and FcγRII [28]. To our understanding NF-κB activating properties of
immunoglobulin isotypes have not yet been investigated. We first tested NF-κB translocation
induced GFP production during incubation of U937-NF-κB on immobilized IgG. We verified
that this activation is indeed mediated by the Fc fragment of IgG as (i) masking antibodies with
anti-human IgG F(ab’)2 inhibited activation, and (ii) hIgG in soluble form did not induce acti-
vation. Immunoglobulin Fc part mediated cross-linking of FcγRI and/or FcγRII, thus, triggers
signaling via NF-κB. As of note the monocyte inflammatory activation is not exclusively con-
trolled by the NF-κB mediated production of cytokines, as FcyR mediated activation by IgG
complexes was shown trigger caspase-1 activity, and thus may potentially contribute to the
production IL-1 superfamily of proinflammatory cytokines [29].
The NF-κB transcription family is well-established as an important regulator of the inflam-
matory immune response [30]. The mechanism of its activation in response to TLR ligands has
been widely studied [31]. Among other cell types monocytes and U937 cells were also investi-
gated, and found to produce tumor necrosis factor-α (TNF-α), macrophage inflammatory pro-
tein 1-β, granulocyte colony stimulating factor (G-CSF) and interleukin-6 in response to LPS,
supporting the inflammatory role of this pathway [12]. These well-known inflammatory cyto-
kines are often found to be elevated in the sera of patients with autoimmune disease, such as
RA [32]. Genome-scale location analysis of U937 after stimulation with LPS showed that more
than 300 genes were affected in a response orchestrated by the five NF-κB family members
[33]. While these studies focused on the binding of NF-κB transcription factor family members
to their target sequences, here we also show the dynamics of the de novo protein synthesis dur-
ing activation, as had been reported by others on luciferase based reporter assays with U937
Fig 6. ACPA detection with the reporter cells. IgG and IgA reactivities of RA patients’ sera were measured
for VCP2 peptide on protein microarray (A). The reactivity was analyzed with anti-IgG and anti-IgA
antibodies, and the results were presented in relative fluorescence intensity (RFI). Ten times diluted RA
serum samples were incubated on VCP2 peptide coat, and then U937-NF-κB cells were placed to the
immuncomplex formed surface. The cell activation was normalized to the untreated cells (on BSA coat).
Kruskal-Wallis and Dunn's multiple comparison tests were carried out to evaluate significant differences
(*p<0.05).
doi:10.1371/journal.pone.0156328.g006
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[34,35]. In agreement with these results, U937-NF-κB cells, in response to LPS, produce GFP
in a dose- and time-dependent manner.
In the current study we compared NF-κB translocation activating properties of immuno-
globulin isotypes separately, which have not been investigated yet. Surprisingly, of the tested
isotypes only IgG3 and IgG4 were found to have robust inflammatory potential, IgG1 had just
a weak effect, whereas IgG2, IgA and IgM elicited no activation. It has to be noted that the vari-
ant R131 of FcγRII shows very little binding of IgG2, thus the relevance of our results regarding
NF-κB activation by IgG2 is not yet conclusive. Investigations with cells expressing the FcγRII
H131 variant is to be performed to verify this finding. However previously it has been shown
that IgG2 immune-complexes can bind to FcγRI as well despite the low affinity of the FcγRI–
IgG2 interaction [36]. Difference in glycosylation could offer an explanation, for the low activa-
tion by IgG1, yet the ability of IgG1 to compete with IgG4 (Fig 4) indirectly shows its binding
to FcγRI, and thus, its weak activating property is not due to differences in glycosylation and
FcγRI binding. In agreement with our findings, it has been shown in vivo that therapeutic IgG1
antibodies exert antibody-dependent cell mediated cytotoxicity (ADCC) and complement-
dependent cytotoxicity (CDC) as effector functions, with a limited pro-inflammatory effect
[37]. The highly activating, pro-inflammatory nature of IgG3 we found is in agreement with
earlier findings showing this subclass to be the most effective in mediating effector functions.
Until recently, IgG4 was thought to be highly inert, mostly because of disassembly of the con-
stituting heavy chains, resulting in monovalent half-antibodies highly capable of neutralization
just as in the case of its reported protective role in allergy. Recently, IgG4 triggered signaling
has been shown [38], and the example of IgG4-related disease demonstrates that high local
concentrations of IgG4 can be pathogenic and cause inflammation [39]. Our results also dem-
onstrate the competition between the IgG subclasses for the high affinity Fc receptor (Fig 4).
Presumably, this competitive saturation also happens in vivo, where during their trafficking to
effector sites, FcγRI molecules of various cells will be saturated by IgG3 antibodies of various
antigen-specificities, thus setting a threshold limit for local antigen specific IgG3 concentration
to enable cell activation, offering a further explanation on the role of FcγRI in immunity
[40,41].
Activation of the NF-κB pathway through FcγRs have been rigorously investigated in
monocytes, and a signaling pathway independent of phagocytosis and actin cytoskeleton rear-
rangement was shown to signal through FcγRI and FcγRII [6]. These results suggest that affin-
ity of immunoglobulins to FcRs does not necessarily reflect the inflammatory response
mediated by these receptors. Lipid raft association of FcγRIIA was also found to be a perquisite
of immunoreceptor tyrosine-based activation motif (ITAM) phosphorylation [42] and NF-κB
activation through this receptor but not for phagocytosis [43], while FcγRI associates with the
lipid-rafts without activation in basal state. Further investigations in U937 cells in response to
activation by FcγRI and FcγRIIa lead to a conclusion that in monocytes, FcγRI shows enhanced
contribution to the inflammatory response [12]. In agreement with these results we found that
in the case of U937-NF-κB cross-linking FcγRs with anti-FcγRI to be a more potent activator
of the NF-κB translocation induced GFP production compared to anti-FcγRII treatment.
U937 cells express no receptors for IgM, and in agreement with this, IgM did not activated
the U937-NF-κB cells (Fig 3). FcαRI, the IgA Fc receptor was shown to be expressed in U937
cells, yet its NF-κB activating potential was not yet demonstrated to our understanding. Cross-
linking these receptors with immobilized IgA did not induce GFP production. Priming of
FcαRI through inside-out signaling by various cytokines, such as G-CSF and granulocyte mac-
rophage colony-stimulating factor (GM-CSF) was shown to be necessary for ligand binding
[44]. In agreement with this, IgA immobilized in combination with IgG3 and IgG4 enhanced
the activation of the NF-κB pathway in a dose-dependent manner as compared to IgG3 and
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IgG4 coats only, while no effect was found for IgG1 and IgG2. Dai et al. have shown that stimu-
lation of FcyRI in U937 cells results in the production of G-CSF, which was found to be an
effective mediator of FcαRI priming in polymorphonuclear leukocytes [12]. Our results suggest
that IgG by activating the NF-κB pathway through FcyRI can prime FcαRI, and thus, link anti-
bodies of IgA isotype into the inflammatory response, as IgA was indeed capable of augment-
ing GFP production in U937-NF-κB cells. It has to be noted that the antibodies used in our
study were monoclonals, and thus, does not necessarily mirror how the NF-κB activation hap-
pens, when stimulated with polyclonal isotype samples.
To further expand our observations and see, if U937-NF-κB cells can detect serum-derived
antigen specific antibodies, we measured GFP production after incubation of VCP2 [45], a
citrullinated peptide, with sera from RA patients. To ensure that complement does not play a
role in the activation, we used EDTA-containing serum dilution buffer. As expected, neither
IgG-IgA-, nor IgG-IgA+ group of samples triggered activation, verifying our previous finding
that IgA alone cannot activate GFP production. Surprisingly, only one sample in the IgG+IgA-
group responded; however, when both antigen specific IgG and IgA were present in the sam-
ples, we found a heterogeneous, yet significant elevation in GFP production (Fig 6). These
results support that IgA can indeed act in combination with IgG during autoimmune reactions,
and this synergistic effect of IgA and IgG can contribute to the inflammation through the NF-
κB pathway. In agreement with our findings a pathogenic role for IgA in RA resulting in more
severe symptoms has been suggested in the literature [46]. Moreover the possible role of ACPA
pathogenicity in RA through activating monocytes and facilitating their differentiation into
osteoclasts has been demonstrated [47]. Monocytes have been also showed as important effec-
tor cells producing inflammatory cytokines upon activation with ACPA in immune complex-
based activation tests [48], establishing the importance of NF-κB translocation in RA
pathogenesis.
Testing cell activating effector functions of ACPA-CCP (cyclic citrullinated peptide)
immune complexes focused mainly on cytokine secretion of macrophages and monocytes so
far (during incubation with the immune complexes). Laurent et al. showed that despite the sig-
nificant alterations in FcγR level expression in monocytes from RA patients [49], monocytes
from healthy controls and RA patients produce comparable levels of TNF-α upon induction by
ACPA-CCP immune complexes [50]. Most of the studies to our understanding demonstrated
this TNF-α production by monocytes in response to immune complexes formed with citrulli-
nated fibrinogen [50–52]. Sokolove et al. proposed that this induction is the consequence of
concomitant activation of the cells by the TLR4 ligand (citrullinated) fibrinogen and the FcγRs
[52]. In agreement with these results a recent review proposes that cytokine production
induced by ligand binding of FcγRs requires the presence of an additional danger signal [1].
However, when testing for TNF-α following stimulation of monocytes by immobilized IgG1
and IgG3, Magnusson et al. showed that monocytes produce TNF-α without CCP or additional
activating signal [53].
Our results show how different antibody isotypes can control inflammation by activating
NF-κB translocation through Fc receptors, demonstrating the role of IgG3 and IgG4, as well as
the proinflammatory contribution of IgA in combination with these subclasses. We also veri-
fied previous data on the proinflammatory role of FcγRI, and finally demonstrated the diagnos-
tic application of U937-NF-κB cells to detect VCP2 based autoimmune immune-complexes.
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